An oligopeptide ligand-mediated therapeutic gene nanocomplex for liver cancer-targeted therapy

Biomaterials

Volumn 33, Issue 7, 2012, Pages 2240-2250

  Liu, M ^a   Li, Z H ^b   Xu, F J ^c   Lai, L H ^a   Wang, Q Q ^a   Tang, G P ^a   Yang, W T ^c  

^a ZHEJIANG UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c BEIJING UNIVERSITY OF CHEMICAL TECHNOLOGY   (China)

Author keywords

AChE; Gene therapy; Target; Tumor; Vector; YC21

Indexed keywords

ACETYLCHOLINESTERASE; ACHE; CANCER CELLS; EPIDERMAL GROWTH FACTOR RECEPTORS; GENE CARRIER; GENE DELIVERY; GENE TRANSFECTION; GENE VECTORS; IN-VITRO; IN-VIVO; LIVER CANCER CELLS; LIVER CANCERS; LOW MOLECULAR WEIGHT; MITOGEN ACTIVATED PROTEIN KINASE; NANOCOMPLEXES; OLIGOPEPTIDES; POLYETHYLENIMINES; THERAPEUTIC GENES; YC21;

AMINO ACIDS; CELL PROLIFERATION; CELLS; DISEASES; GENE EXPRESSION; GENE TRANSFER; LIGANDS; MOLECULAR BIOLOGY; TARGETS; TUMORS; VECTORS;

GENE THERAPY;

ACETYLCHOLINESTERASE; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; OLIGOPEPTIDE; PHOSPHATIDYLINOSITOL 3 KINASE;

ANIMAL EXPERIMENT; ARTICLE; CANCER GENE THERAPY; CELL PROLIFERATION; ENZYME INACTIVATION; FEMALE; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; IN VITRO GENE TRANSFER; IN VIVO GENE TRANSFER; LIVER CANCER; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ACETYLCHOLINESTERASE; ANIMALS; CELL LINE, TUMOR; FEMALE; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; LIGANDS; LIVER NEOPLASMS; MATERIALS TESTING; MICE; MICE, INBRED BALB C; MOLECULAR STRUCTURE; OLIGOPEPTIDES; POLYETHYLENEIMINE; RECEPTOR, EPIDERMAL GROWTH FACTOR; TRANSFECTION;

EID: 84855739041     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.11.082     Document Type: Article

References (29)

1. Zeng X., Sun Y.X., Zhang X.Z., Zhuo R.X. Biotinylated disulfide containing PEI/avidin bioconjugate shows specific enhanced transfection efficiency in HepG2 cells. Org Biomol Chem 2009, 7:4201-4210.
2. Ishii M., Iwai M., Harada Y., Kishida T., Asada H., Shin-Ya M., et al. Soluble TRAIL gene and actinomycin D synergistically suppressed multiple metastasis of TRAIL-resistant colon cancer in the liver. Cancer Lett 2007, 245:134-143.
3. Zhao Y., Wang X., Wang T., Hu X., Hui X., Yan M., et al. Acetylcholinesterase, a key prognostic predictor for hepatocellular carcinoma, suppresses cell growth and induces chemosensitization. Hepatology 2011, 53:493-503.
4. Pegan K., Matkovic U., Mars T., Mis K., Pirkmajer S., Brecelj J., et al. Acetylcholinesterase is involved in apoptosis in the precursors of human muscle regeneration. Chem Biol Interact 2010, 187:96-100.
5. Layer P.G., Allebrandt K., Andermann P., Bodur E., Boopathy R., Bytyqi A.H., et al. On the multifunctionality of cholinesterases. Chem Biol Interact 2005, 157/158:37-41.
6. Hu Y., Li K., Wang L., Yin S., Zhang Z., Zhang Y. Pegylated immuno-lipopolyplexes: a novel non-viral gene delivery system for liver cancer therapy. JControl Release 2010, 144:75-81.
7. Demeneix B., Behr J., Boussif O., Zanta M.A., Abdallah B., Remy J. Gene transfer with lipospermines and polyethylenimines. Adv Drug Deliv Rev 1998, 30:85-95.
8. Godbey W.T., Wu K.K., Mikos A.G. Size matters: molecular weight affects the efficiency of poly(ethylenimine) as a gene delivery vehicle. JBiomed Mater Res 1999, 45:268-275.
9. Boussif O., Lezoualch F., Zanta M.A., Mergny M.D., Scherman D., Demeneix B., et al. Aversatile vector for gene and oligonucleotide transfer into cells in culture and in-vivo - polyethylenimine. Proc Natl Acad Sci USA 1995, 92:7297-7301.
10. Dehshahri A., Oskuee R.K., Shier W.T., Hatefi A., Ramezani M. Gene transfer efficiency of high primary amine content, hydrophobic, alkyl-oligoamine derivatives of polyethylenimine. Biomaterials 2009, 30:4187-4194.
11. Veiseh O., Kievit F.M., Gunn J.W., Ratner B.D., Zhang M. Aligand-mediated nanovector for targeted gene delivery and transfection in cancer cells. Biomaterials 2009, 30:649-657.
12. Liu P.F., Li Z.H., Zhu M.J., Sun Y., Li Y.G., Wang H.Z., et al. Preparation of EGFR monoclonal antibody conjugated nanoparticles and targeting to hepatocellular carcinoma. JMater Sci Mater M 2010, 21:551-556.
13. Song S., Liu D., Peng J., Sun Y., Li Z., Gu J.R., et al. Peptide ligand-mediated liposome distribution and targeting to EGFR expressing tumor invivo. Int J Pharm 2008, 363:155-161.
14. Huang H., Yu H., Tang G., Wang Q., Li J. Low molecular weight polyethylenimine cross-linked by 2-hydroxypropyl-gamma-cyclodextrin coupled to peptide targeting HER2 as a gene delivery vector. Biomaterials 2010, 31:1830-1838.
15. Chiu S.J., Ueno N.T., Lee R.J. Tumor-targeted gene delivery via anti-HER2 antibody (trastuzumab, Herceptin) conjugated polyethylenimine. JControl Release 2004, 97:357-369.
16. Wu X., Zhao R., Li Z., Yao M., Wang H., Han J., et al. Anovel small peptide as a targeting ligand for receptor tyrosine kinase Tie2. Biochem Biophys Res Commun 2004, 315:1004-1010.
17. Li Z., Zhao R., Wu X., Sun Y., Yao M., Li J., et al. Identification and characterization of a novel peptide ligand of epidermal growth factor receptor for targeted delivery of therapeutics. FASEB J 2005, 19:1978-1985.
18. Yao H., Ng S.S., Tucker W.O., Tsang Y.K.T., Man K., Wang X.M., et al. The gene transfection efficiency of a folate-PEI600-cyclodextrin nanopolymer. Biomaterials 2009, 30:5793-5803.
19. Jiang Q.Y., Lai L.H., Shen J., Wang Q.Q., Xu F.J., Tang G.P. Gene delivery to tumor cells by cationic polymeric nanovectors coupled to folic acid and the cell-penetrating peptide octaarginine. Biomaterials 2011, 32:7253-7262.
20. Huang H.L., Yu H., Li D., Liu Y., Shen F., Zhou J., et al. Anovel co-polymer based on hydroxypropyl alpha-cyclodextrin conjugated to low molecular weight polyethylenimine as an invitro gene delivery vector. Int J Mol Sci 2008, 9:2278-2289.
21. Tang G.P., Guo H.Y., Alexis F., Wang X., Zeng S., Lim T.M., et al. Low molecular weight polyethylenimines linked by beta-cyclodextrin for gene transfer into the nervous system. JGene Med 2006, 8:736-744.
22. Chen D., Ping Y., Tang G.P., Li J. Polyethyleneimine-grafted poly(N-3-hydroxypropyl)aspartamide as a biodegradable gene vector for efficient gene transfection. Soft Matter 2010, 6:955-964.
23. Koh S.H., Noh M.Y., Cho G.W., Kim K.S., Kim S.H. Erythropoietin increases the motility of human bone marrow-multipotent stromal cells (hBM-MSCs) and enhances the production of neurotrophic factors from hBM-MSCs. Stem Cells Dev 2009, 18:411-421.
24. Kurtoglu Y.E., Navath R.S., Wang B., Kannan S., Romero R., Kannan R.M. Poly(amidoamine) dendrimer-drug conjugates with disulfide linkages for intracellular drug delivery. Biomaterials 2009, 30:2112-2121.
25. Yang C.A., Li H.Z., Goh S.H., Li J. Cationic star polymers consisting of alpha-cyclodextrin core and oligoethylenimine arms as nonviral gene delivery vectors. Biomaterials 2007, 28:3245-3254.
26. Naruse I., Ohmori T., Ao Y., Fukumoto H., Kuroki T., Mori M., et al. Antitumor activity of the selective epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) Iressa (R) (ZD1839) in an EGFR-expressing multidrug-resistant cell line invitro and invivo. Int J Cancer 2002, 98:310-315.
27. Ogris M., Wagner E. Tumor-targeted gene transfer with DNA polyplexes. Somat Cell Mol Genet 2002, 27:85-95.
28. Wang H., Jiang H., Zhou M., Xu Z., Liu S., Shi B., et al. Epidermal growth factor receptor vIII enhances tumorigenicity and resistance to 5-fluorouracil in human hepatocellular carcinoma. Cancer Lett 2009, 279:30-38.
29. Le Tourneau C., Vidal L., Siu L.L. Progress and challenges in the identification of biomarkers for EGFR and VEGFR targeting anticancer agents. Drug Resist Updat 2008, 11:99-109.